Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 4Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Multiple Myeloma 66Recurrence 20Neoplasms, Plasma Cell 8Primary Myelofibrosis 3Polycythemia Vera 3Myeloproliferative Disorders 3Renal Insufficiency 2Plasmacytoma 2Lymphoma, Non-Hodgkin 2Immunoglobulin Light-chain Amyloidosis 2Central Nervous System Neoplasms 2Waldenstrom Macroglobulinemia 1Unspecified Adult Solid Tumor, Protocol Specific 1Thrombocytosis 1Thrombocythemia, Essential 1Sarcoma, Kaposi 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Optic Nerve Glioma 1Neurofibromatosis 1 1Neoplasms 1Medulloblastoma 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell 1Leukemia, Plasma Cell 1Leukemia, Myeloid, Acute 1Leukemia, Megakaryoblastic, Acute 1Intraocular Lymphoma 1Hodgkin Disease 1Glioma 1

Interventions

Rituximab 187Cyclophosphamide 174Etoposide 94Peripheral Blood Stem Cell Transplantation 90Vincristine 89Prednisone 80Doxorubicin 79Filgrastim 75fludarabine phosphate 60Radiotherapy 56Mycophenolic Acid 41Melphalan 41Cytarabine 41Busulfan 40Cyclosporine 39Methotrexate 37Whole-Body Irradiation 36Tacrolimus 35Carmustine 34Ifosfamide 28Lenalidomide 27Granulocyte Colony-Stimulating Factor 27Antilymphocyte Serum 27Gemcitabine 25Carboplatin 25Methylprednisolone 24ibritumomab tiuxetan 23Bortezomib 22Dexamethasone 21ibrutinib 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Lymphoma, Large B-Cell, Diffuse × pomalidomide × Clear all
NCT01722305 2019-07-22

Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma or Newly Diagnosed or Relapsed or Refractory Intraocular Lymphoma

Mayo Clinic

Phase 1 Completed
29 enrolled
Lymphoid

Burkitt Lymphoma, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Intraocular Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡